Cardiac inflammation biomarker test company Cleveland HeartLab has been tapped as the Ohio Venture Association‘s ” venture of the year.”
The last year has been an eventful one for the Cleveland-based company: It spurned a buyout offer from an unidentified Massachusetts suitor, closed an $18.4 million series B round of investment, moved into a new building that quadrupled its office space, made a splash at TEDMED and is eyeing a new market — health and wellness. [Read More at medcitynews.com]